| Project/Area Number |
05670212
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Experimental pathology
|
|---|
| Research Institution | National Institute of Health |
|---|
Principal Investigator |
SUZUKI Kazuo National Institute of Health, Bioactive Mol., Lab Chief., 生物活性物質部, 室長 (20192130)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
OKAWARA Akiko National Institute of Health, Bioactive, Mol., Res.Associate, 生物活性物質部, 研究員 (30260277)
SASAKI Tsuguo National Institute of Health, Sefity Res., Lab Chief, 安全性研究部, 室長 (60142139)
YAMAKAWA Yoshio National Institute of Health, Cell, Biochem., Senior Researcher, 細胞化学部, 主任研究官 (50100102)
|
|---|
| Project Period (FY) |
1993 – 1995
|
| Project Status |
Completed (Fiscal Year 1995)
|
| Budget Amount *help |
¥2,400,000 (Direct Cost: ¥2,400,000)
Fiscal Year 1995: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1994: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1993: ¥800,000 (Direct Cost: ¥800,000)
|
|---|
| Keywords | autoimmune disease, / myeloperoxidase, / MPO, / neutrophils, / ANCA, / glomerulonephritis / 腎炎 / リウマチ / ミエロパーオキシダーゼ / ミエロオパーオキシダーゼ / ミエロペルオキダーゼ |
|---|
| Research Abstract |
In pauci-immune necrotizing crescentic glomerulonephritis (NCGN) autoimmune disease, anti myeloperoxidase (MPO) -antibody increase in peripheral blood of the patients.Determination of epitopes of anti-MPO antibody in some autoimmune diseases such as NCGN my give us a clue to the etiology and be used for prediction of the diseases.We have demonstrated three types of MPO (I,II,and III) and that some sera of GN reacted with the large subunit (59 kDa) of MPO-III,but not to the small subunit (14 kDa).As one serum of them most strongly reacts with a 55-kDa-deglycosylated form derived from the 59-kDa large subunit, we have attempted to prepare some recombinant the large fragments of large subunit.
In the present study, we prepared the recombinant MPO-fragments as panels to analyze epitope of serum of patient with autoimune disease.cDNA encoding 59 kDa-subunit (large) of MPO was amplified by PCR in 12 parts and these cDNAs were separately inserted into the vector.The recombinant MPO fragments were expressed in E.coli and were digested with guanidine hydrochloride in a sonicator.The fragments were purified with an affinity column chromatography.The obtained fragments were used for western blot analysis to determine the reactivity of sera of patients.Some sera reacted with the MPO fragments containing Met409.The results confirmed the recognition site in native MPO-III molecule by an anti-MPO serum is around sugar attachment sites in the N-terminus in the large subunit of MPO.
|
